various icons about the lab

Laboratory of Bacterial Infection

  • Research
  • Members
  • Publications

Research Synopsis

     Many Gram-negative bacteria possess the type III secretion system (T3SS), which is referred to as the needle complex. The needle structure of this complex protrudes from the bacterial outer membrane, and bacterial proteins are delivered into the host when the needle structure interacts with the host plasma membrane. Any bacterial protein that perturbs the physiology of the host by translocation into host cells via T3SS is generally called an “effector”. The effector has an important role in the bacterial disease process. Recent research has demonstrated that the long-term settlement of the Bordetella species including B. pertussis is dependent on T3SS, but its mechanism has remained unclear. At our laboratory, we have clarified that BopN, which is translocated into the host via T3SS, induces the production of the anti-inflammatory cytokine IL-10, and that BopC is an effector that causes cell death. Thus, the mechanism of avoiding host immune responses using effectors has been gradually disclosed. Our laboratory has elucidated the infective strategy of Bordetella bacteria on the molecular level and is utilizing this information for the development of vaccines.

Effector function of Bordetella bacteria
BopN suppresses the inflammatory response at the infected section
  • Laboratory of Bacterial Infection

Staff

Abe Akio
Abe Akio
Professor
Kuwae Asaomi
Kuwae Asaomi
Associate Professor

2012

  1. Jun Kurushima, Asaomi Kuwae, Akio Abe : The Type III Secreted Protein BspR Regulates the Virulence Genes in Bordetella bronchiseptica, PLoS ONE 7(6): e38925, 2012
  2. Jun Kurushima, Asaomi Kuwae, Akio Abe : Btc22 chaperone is required for secretion and stability of the type III secreted protein Bsp22 in Bordetella bronchiseptica, FEMS Microbiol. Lett., 331: 144-151, 2012
  3. Jun Kurushima, Asaomi Kuwae, Akio Abe : Iron starvation regulates the type III secretion system in Bordetella bronchiseptica, Microbiology and Immunology, 56: 356-362, 2012
  4. Toshio Fukasawa, Akio Abe, Atsusi Nakamura, Miyako Horigome, Akira Naito : Solid-state NMR spectroscopy reveals anomer specific transport of galactose in the milk yeast Kluyveromyces lactis, FEMS Yeast Res., 12: 415-422, 2012

2011

  1. 阿部章夫,桑江朝臣 : 病原細菌のエフェクターの分泌機構と病原性発揮の分子機構, 感染 炎症 免疫, 41: 2-11, 2011
  2. Hyun-Ja Han, Asaomi Kuwae, Akio Abe, Yoshichika Arakawa, Kazunari Kamachi : Differential expression of type III effector BteA protein due to IS481 Insertion in Bordetella pertussis, PLoS ONE, 6: e17797, 2011
  3. Kyota Kimura, Masato Iwatsuki, Takeshi Nagai, Atsuko Matsumoto, Yoko Takahashi, Kazuro Shiomi, Satoshi Omura and Akio Abe : A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium, The Journal of Antibiotics, 64: 197-203, 2011

2010

  1. Eiji Komatsu, Fuminori Yamaguchi, Akio Abe, Alison A. Weiss, and Mineo Watanabe : Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model, Clin Vaccine Immunol., 17: 807-12, 2010
  2. Jun Kurushima, Takeshi Nagai, Kanna Nagamatsu, Akio Abe : EspJ effector in enterohemorrhagic E. coli translocates into host mitochondria via an atypical mitochondrial targeting signal, Microbiology and Immunology, 54: 371-379, 2010